glp 1/gip vs glp 1 Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic
Description
Real-world data from a Truveta study of over 18,000 patients found that tirzepatide users achieved greater weight loss at 12 months compared to semaglutide users, consistent with the SURMOUNT-5 findings [4]
doi: 10.1210/jc.2013-4379
Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported
Dulaglutide (Trulicity) begins at 0.75 mg once weekly, with potential increases to 1.5 mg, 3 mg, or a maximum of 4.5 mg weekly based on glycemic response
Top with sliced banana and a tablespoon of almond butter
